Dxome Overview

  • Year Founded
  • 2017

Year Founded

  • Status
  • Private

  • Employees
  • 32

Employees

  • Latest Deal Type
  • Series A

  • Investors
  • 6

Dxome General Information

Description

Developer of a digital diagnostic technology device designed to offer clinical data insights. The company's system offers screening panels and detection kits that allow hospitals to detect information using next-generation sequencing and real-time PCR, enabling clinicians to detect and treat infectious diseases on time.

Contact Information

Website
www.dxome.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 8, Seongnam-daero 331beon-gil
  • Bundang-gu, Jeongja-dong, Kins Tower
  • Seongnam, Gyeonggi
  • South Korea
+82
Primary Industry
Diagnostic Equipment
Other Industries
Decision/Risk Analysis
Biotechnology
Vertical(s)
HealthTech, Life Sciences
Corporate Office
  • 8, Seongnam-daero 331beon-gil
  • Bundang-gu, Jeongja-dong, Kins Tower
  • Seongnam, Gyeonggi
  • South Korea
+82

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Dxome Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Early Stage VC (Series A) 13-Mar-2019 Completed Startup
To view Dxome’s complete valuation and funding history, request access »

Dxome Patents

  • 8

    Total Documents Applications and Grants

  • Total Patents Families

  • 4

    Granted

  • 4

    Pending

  • Expiring in next 12 mo

Dxome Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4496799-A2 Method of sequencing l-polynucleotide Pending 22-Mar-2022
US-20250215489-A1 Method of sequencing l-polynucleotide Pending 22-Mar-2022
EP-3831910-A1 Method for producing graphene quantum dots Pending 07-Sep-2018
EP-3831910-A4 Method for producing graphene quantum dots Pending 07-Sep-2018
US-11718531-B2 Method for producing graphene quantum dots Active 07-Sep-2018 C01B32/225
To view Dxome’s complete patent history, request access »

Dxome Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Dxome Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds
AJU IB Investment Venture Capital Minority
Brightstar Partners (UK) Venture Capital Minority
ID Ventures (South Korea) Venture Capital Minority
Kiwoom Investment Venture Capital Minority
Korea Development Bank Investment Bank Minority
You’re viewing 5 of 6 investors. Get the full list »

Ready to get started?

Request a free trial

Dxome FAQs

  • When was Dxome founded?

    Dxome was founded in 2017.

  • Where is Dxome headquartered?

    Dxome is headquartered in Seongnam, South Korea.

  • What is the size of Dxome?

    Dxome has 32 total employees.

  • What industry is Dxome in?

    Dxome’s primary industry is Diagnostic Equipment.

  • Is Dxome a private or public company?

    Dxome is a Private company.

  • What is Dxome’s current revenue?

    The current revenue for Dxome is .

  • Who are Dxome’s investors?

    AJU IB Investment, Brightstar Partners (UK), ID Ventures (South Korea), Kiwoom Investment, and Korea Development Bank are 5 of 6 investors who have invested in Dxome.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »